In Palantir's Q2 earnings report on Aug. 4, investors should watch this trend to see if commercial AI adoption is starting to ...

Deals over $1 million are gaining steam. We believe this is a more valuable signal than deals over $10 million in terms of ...

Now, it’s worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

As cryptocurrencies and shares of unprofitable and highly shorted stocks soar, talk of a bubble forming in financial markets has again started to percolate on Wall Street.

Palantir is scheduled to report second-quarter earnings in the next week, and expectations are sky high. Is now a good time ...

Palantir is making significant progress towards expanding its software platform across government agencies. Click here to ...

Palantir's stock has more than doubled in 2025 -- here's why the upcoming earnings could decide whether it soars even higher ...

Palantir's Q2 2025 earnings are expected to impress with 39% YoY revenue growth, but lofty valuations pose risks.

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

The data mining and artificial intelligence (AI) specialist is firing on all cylinders, but the answer is still complicated.

Two companies have recently seen their stock prices head higher on optimism about the future growth in AI spending. Palantir ...